Ani Pharmaceuticals (ANIP) Receivables (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Receivables of $255.4 million for Q1 2026, down 9.13% sequentially from $281.1 million in Q4 2025, and up 15.93% YoY from $220.3 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Receivables (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Receivables for 15 years, with the latest figure at $255.4 million in Q1 2026.
- Quarterly Receivables rose 15.93% year-over-year to $255.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $255.4 million (up 15.93% YoY) and the FY2025 annual result came in at $281.1 million, up 26.77% from the prior year.
- Receivables slipped to $255.4 million in Q1 2026 per ANIP's latest filing, from $281.1 million in the prior quarter.
- Over five years, Receivables peaked at $281.1 million in Q4 2025 and troughed at $131.6 million in Q1 2022.
- A 5-year average of $192.2 million and a median of $174.7 million in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2024: Receivables surged 62.35% in 2022, then declined 3.95% in 2024.
- Over 5 years, Receivables stood at $165.4 million in 2022, then slipped by 2.03% to $162.1 million in 2023, then jumped by 36.8% to $221.7 million in 2024, then climbed by 26.77% to $281.1 million in 2025, then slipped by 9.13% to $255.4 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $255.4 million, $281.1 million, and $252.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 274.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 274.47 Mn |
| Mar 31, 2026 | 255.43 Mn |
| Dec 31, 2025 | 281.08 Mn |
| Sep 30, 2025 | 252.62 Mn |
| Jun 30, 2025 | 225.65 Mn |
| Mar 31, 2025 | 220.33 Mn |
| Dec 31, 2024 | 221.73 Mn |
| Sep 30, 2024 | 196.36 Mn |
| Jun 30, 2024 | 166.09 Mn |
| Mar 31, 2024 | 172.42 Mn |
| Dec 31, 2023 | 162.08 Mn |
| Sep 30, 2023 | 178.84 Mn |
| Jun 30, 2023 | 172.93 Mn |
| Mar 31, 2023 | 174.71 Mn |
| Dec 31, 2022 | 165.44 Mn |
| Sep 30, 2022 | 140.43 Mn |
| Jun 30, 2022 | 150.41 Mn |
| Mar 31, 2022 | 131.63 Mn |
| Dec 31, 2021 | 128.53 Mn |
| Sep 30, 2021 | 106.71 Mn |